Lymphurgy is a bladder surgery to remove lymph nodes and ureters for bladder tumors.
It is used in cases where the tumor was partially or completely removed, but after surgery relapses began, which indicates the presence of metastases in the lymph node. Lymphometastases have not yet spread to the surrounding organs, i.e. there is no damage to all fiber, lymph nodes, and internal organs. In such cases, the operation is performed immediately. Since there is a threat of malignant metastases to the pelvic organs, lymph node dissection is performed (complete removal of lymph collectors).
**Indications for lymphadenectomy**:
— transmural bladder cancer T2-4N0, condition after cystectomy;
- invasive cancer Tis-2N0 with flat, flat-infiltrating cancer. Distant metastases to the lymph nodes are extremely rare, however, patients need to be under the supervision of a urologist and undergo regular cystoscopy and ultrasound. If a new lesion appears, it must be removed;
- bladder cancer involving the inguinal nodes. If lymph node dissection is performed for Tis-2, then subsequent relapses are detected very rarely. Lymphorrhea after removal of metastatic nodes should not exceed 20-30 ml/hour after three days from the start of intensive therapy. If the data is higher, a systematic blood test begins for biochemical indicators of the liver, kidneys, and coagulation system in order to promptly identify the advanced process; - all types of neoplasms localized in the bed of the removed bladder - residual tumors, fistulas, etc.